1. Kamada, Rui, Kudoh, Fuki, Ito, Shogo, Omichinski, James G, Sakaguchi, Kazuyasu. 2020. Metal-dependent Ser/Thr protein phosphatase PPM family: Evolution, structures, diseases and inhibitors. In Pharmacology & therapeutics, 215, 107622. doi:10.1016/j.pharmthera.2020.107622. https://pubmed.ncbi.nlm.nih.gov/32650009/
2. Zhang, Rui, Yuan, Jinglei, Liu, Shicheng, Zhou, Cefan, Tang, Jingfeng. 2024. ILKAP Promotes the Metastasis of Hepatocellular Carcinoma Cells by Inhibiting β-Catenin Degradation and Enhancing the WNT Signaling Pathway. In Advanced biology, 8, e2300117. doi:10.1002/adbi.202300117. https://pubmed.ncbi.nlm.nih.gov/38379270/
3. Hausmann, Christina, Temme, Achim, Cordes, Nils, Eke, Iris. . ILKAP, ILK and PINCH1 control cell survival of p53-wildtype glioblastoma cells after irradiation. In Oncotarget, 6, 34592-605. doi:10.18632/oncotarget.5423. https://pubmed.ncbi.nlm.nih.gov/26460618/
4. Zhou, Wang, Cui, Shusen, Han, Shuhai, Zheng, Yu, Zhang, Yingjiu. 2011. Palladin is a novel binding partner of ILKAP in eukaryotic cells. In Biochemical and biophysical research communications, 411, 768-73. doi:10.1016/j.bbrc.2011.07.022. https://pubmed.ncbi.nlm.nih.gov/21782789/
5. Arroyo-Berdugo, Yoana, Alonso, Santos, Ribas, Gloría, Asumendi, Aintzane, Boyano, María Dolores. 2014. Involvement of ANXA5 and ILKAP in susceptibility to malignant melanoma. In PloS one, 9, e95522. doi:10.1371/journal.pone.0095522. https://pubmed.ncbi.nlm.nih.gov/24743186/
6. Zhang, Xing, Ning, Yichong, Xiao, Yuzhong, Jiang, Dejian, Zhou, Jianlin. 2017. MAEL contributes to gastric cancer progression by promoting ILKAP degradation. In Oncotarget, 8, 113331-113344. doi:10.18632/oncotarget.22970. https://pubmed.ncbi.nlm.nih.gov/29371914/
7. Leung-Hagesteijn, C, Mahendra, A, Naruszewicz, I, Hannigan, G E. . Modulation of integrin signal transduction by ILKAP, a protein phosphatase 2C associating with the integrin-linked kinase, ILK1. In The EMBO journal, 20, 2160-70. doi:. https://pubmed.ncbi.nlm.nih.gov/11331582/
8. Lorenzato, Annalisa, Torchiaro, Erica, Olivero, Martina, Di Renzo, Maria Flavia. 2016. The integrin-linked kinase-associated phosphatase (ILKAP) is a regulatory hub of ovarian cancer cell susceptibility to platinum drugs. In European journal of cancer (Oxford, England : 1990), 60, 59-68. doi:10.1016/j.ejca.2016.02.022. https://pubmed.ncbi.nlm.nih.gov/27065457/